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Abstract
Background: New findings on adipose tissue physiology and obesity-associated inflammation status suggest that modification of
the adipokine level can be relevant for the long-term prevention of obesity-associated chronic disease.
Objectives: The scope of the present study was to investigate the effectiveness of physical exercise in reducing the systemic
inflammation related to obesity in children.
Methods: We conducted a systematic review with meta-analysis of controlled randomized trials, identified through electronic
database search, which investigated the effect of physical exercise, without concomitant dietary intervention, on adiponectin, leptin, and/
or other inflammatory markers in children up to age 18 years with a body mass index greater than the 95th percentile for age and sex.
Results: Seven trials were included in the meta-analysis, with a total of 250 participants. Compared with the control group without
any lifestyle modification, the physical exercise resulted in a reduction in leptin [standardized mean difference (SMD) -1.13; 95%
confidence interval (95%CI): -1.89 to -0.37; I2 = 79.9%] and interleukin-6 (SMD -0.84; 95%CI: -1.45 to -0.23, I2 = 0.9%) and an
increase in adiponectin plasma concentration (SMD 0.69; 95%CI: 0.02–1.35; I2 = 74.3%).
Conclusions: These results indicate that physical exercise improved the inflammatory state in children with obesity. It is unclear
whether this effect can reduce the risk of cardiovascular and metabolic disease in adulthood. Clinical trials with a uniform intervention
protocol and outcome measurements are required to put our knowledge on adipose tissue biology into a clinical perspective.
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Introduction
N
otwithstanding the evidence linking excess body fat
at a young age to type 2 diabetes and coronary heart
disease in adult years,1 childhood obesity continues
to rise in Europe.2 Based on experimental data accumu-
lated over the last decade, adipose tissue is a metaboli-
cally active organ, able to respond to incoming signals
and secrete several adipokines involved in modulating the
metabolic processes and inflammatory responses in an
endocrine manner.3 Circulating levels of adipokines reach
a characteristic profile in specific metabolic states.4 Im-
portantly, logistic analysis indicates that some peptide
hormones released by adipocytes are strictly associated
with obesity.5 Leptin and adiponectin are two such adi-
pokines that act on several target organs, including the
brain, liver, pancreas, muscle, immune system, and adi-
pose tissue itself.
1Department of Public Health, Human Anatomy, and Sports Medicine Section, University of Naples ‘‘Federico II,’’ Naples, Italy.
2Department of Neuroscience and Rehabilitation, Centre for Sports Medicine and Disability, Santobono-Pausilipon Children’s Hospital,
Naples, Italy.
*These authors are joint senior authors.
ª Felice Sirico et al., 2018; Published by Mary Ann Liebert, Inc. This Open Access article is distributed under the terms of the Creative Commons
Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use, distribution, and
reproduction in any medium, provided the original author(s) and the source are credited.
CHILDHOOD OBESITY
May/June 2018 j Volume 14, Number 4
Mary Ann Liebert, Inc.
DOI: 10.1089/chi.2017.0269
207
Leptin is able to signal energy sufficiency; its action on
the central nervous system, mainly hypothalamic neuroen-
docrine cells, and on peripheral tissues, including muscle
and pancreatic islet cells, results in reduced food intake
and increased energy expenditure.3 Interestingly, common
forms of obesity are characterized by an elevated, rather
than reduced, concentration of leptin in plasma,6 which
suggests leptin resistance in individuals with obesity.7 The
main targets of adiponectin are the liver and skeletal muscle,
where adiponectin acts to reduce glucose production and
to increase insulin sensitivity and energy expenditure. In
contrast to leptin, adiponectin levels are usually reduced in
subjects with obesity.5,8
Apart from their metabolic effects, both adipokines are
involved in inflammation and immune response, with lep-
tin having proinflammatory and adiponectin having anti-
inflammatory properties. In particular, high levels of leptin
activate monocytes and macrophages to produce IL-6
and tumor necrosis factor (TNF)a. The latter stimulates
expression of leptin and its receptor. One effect of adipo-
nectin is the reduction of TNFa production in macro-
phages.9 On the one hand, the levels of leptin (positively)
and adiponectin (negatively) correlate with body mass in-
dex (BMI)10; on the other hand, obesity is associated with a
low-grade systemic inflammation,11 which has been cor-
related with cardiovascular events, metabolic syndrome,
and diabetes.12 In light of these relationships, a continuum
emerges between obesity, inflammation, and metabolic dis-
ease. Given the role of adipokines in inflammation and
cardiovascular pathophysiology, development of effective
and validated methods to control obesity in childhood is a
rational approach to prevent major diseases in adulthood.13
Childhood obesity does not permanently increase car-
diovascular risk provided that it is successfully treated.
However, bad habits are difficult to eradicate and, accord-
ing to studies, over 80% of those with obesity as children
have obesity as adults.1 In children, making better food
choices and becoming active are the most commonly sug-
gested measures; the same generally applies to adults with
overweight and obesity. However, the loss of body weight
cannot be the main target of these lifestyle interventions.
First, contrary to the loss of body fat, the loss of lean mass
can have negative effects on mortality; second, loss of body
fat does not offer the same benefits as an increase in lean
mass.14 From these observations, it follows that the type and
modality of intervention can be essential to the overall goal;
the interventions that target systemic inflammation could
help to reduce chronic disease risk in the long term.
Systematic reviews of interventions aimed at reducing
obesity have considered a combined effect of exercise and
diet on body mass, body composition, lipid, and glucose
levels.15,16 Diet and exercise, however, can have different
effects on adipose tissue distribution, composition, and ac-
tivity. It has been shown that being physically active reduces
the risk of all-cause mortality17 and that positive effects
of physical exercise extend well beyond its effect on BMI.18
In the light of new findings on adipose tissue physiology
and obesity-associated inflammation status, modification of
the adipokine level and signaling due to changes in adipose
tissue quality, rather than quantity, can be relevant for the
long-term prevention of obesity-associated chronic disease.
Hence, we have chosen to summarize, through a system-
atic approach, available evidence on the impact of physi-
cal activity on adiponectin, leptin, and other inflammatory
markers in children with obesity.
Methods
The study followed the Preferred Reporting Items for
Systematic Reviews and Meta-Analyses (PRISMA) Guide-
lines.19 The PRISMA Checklist is reported in the Supple-
mentary Table S1; (Supplementary Data are available online
at www.liebertpub.com/chi).
Search Strategy
The following databases were searched from inception to
March 2017: PubMed, Web of Science, Medline, Scopus,
and CINAHL databases. English language restriction was
applied. According to the syntax rules of each database, the
following terms were logically combined to search sources
related to the main topic of the analysis: obesity AND
(children OR childhood) AND [(inflammation OR inflam-
matory markers OR adiponectin OR leptin OR (interleukin-
6 OR IL-6) OR (CRP OR C-reactive protein) OR (TNF-a
OR tumor necrosis factor-a)] AND (physical exercise OR
physical activity OR sport OR exercise). Full search strat-
egy for PubMed database is reported in the Supplementary
Table S2. Observational studies, cohort studies, narrative
and systematic reviews, case reports, and case series were
excluded. In addition, the reference lists of relevant articles
were scanned to identify other published and not indexed
sources. All studies identified through database and manual
searches were collected in a reference manager software.
After removal of duplicates, two authors (F.S. and A.B.)
independently reviewed the titles and abstracts. Incon-
sistencies were discussed with another author (D.N.). The
two authors who reviewed the titles and abstracts then in-
dependently analyzed the full text of the remaining articles
to determine final inclusion.
Selection Criteria
The inclusion criteria were as follows: (1) participants
male and/or female at a mean age of 18 years or younger,
with obesity, defined as BMI greater than the 95th percen-
tile for age and sex, (2) supervised intervention consisting
in physical exercise programme, (3) comparison to control
with no change in lifestyle or activity, (4) outcome con-
sisting in a change of the inflammatory marker level, and (5)
controlled randomized and nonrandomized trials published
in English language. Studies with combined interventions of
any type and, in particular, those with concomitant nutri-
tional counseling or dietary intervention were excluded.
Also, data regarding normal weight or overweight patients
were not considered.
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Data Extraction
Two authors (F.S. and A.B.) independently extracted
data from selected studies, compiling a purposefully de-
signed form, including the following: study characteristics
(first author’s surname, year of publication, journal of
publication), participant characteristics (sample size, age,
and sex), experimental design (groups of treatment, type,
frequency, and intensity of physical activity administered
as the intervention, length of intervention in weeks), out-
come assessment (main outcome measures and type of
inflammatory marker measured, changes in the outcome).
Another author (D.N.) compared the extraction forms; all
differences were reviewed, discussed and corrected. The
corresponding authors of the studies that met all inclusion
criteria, but did not report sufficient quantitative data, were
contacted by email. If data were not received, the study
was considered for qualitative analysis only.
Risk of Bias
Studies included in qualitative and quantitative analysis
were assessed independently for risk of bias by two authors
(F.S. and A.B.), using the guidelines included in the Co-
chrane Handbook for Systematic Review of Interventions.20
The following sources of bias were assessed: random
sequence generation, allocation concealment, blinding of
participants and personnel, blinding of outcome assess-
ment, incomplete outcome data, selective reporting, and
other sources of bias (specified and explained in each
case). Each domain was given a quality score of high or
low risk of bias. If data were insufficient to make a rea-
sonable judgment, the domain was classified as unclear
risk of bias. Another author (D.N.) was consulted when
discrepancies occurred on comparison of the two inde-
pendent assessments. We did not perform the Egger test to
assess the publication bias because the number of included
studies was lower than 10. The risk of bias was reported
graphically using Review Manager v.5.3 software.21
Statistical Analyses
All analyses were performed using STATA software
v.12 (StataCorp LP). The effect size and 95% confidence
intervals (95%CI) of each included study were calculated
using the metan routine. The number of patients, mean
difference, and pooled standard deviation were considered
for each group of treatment. When quantitative data re-
garding outcome were reported in different units, the ef-
fect size was calculated as standardized mean difference
(SMD). The mean difference and standard deviation of
parameters from preintervention and postintervention were
calculated, as suggested by the Cochrane guidelines for the
analysis of clinical trials. For those studies that randomized
participants with obesity into three groups (e.g., control
group and two intervention groups with different exercise
protocols), the data of every intervention group were in-
dependently compared with the data of the control group.
The random-effects model was chosen and the presence
of heterogeneity was assessed using the Q statistics, based
on the DerSimonian–Laird approach.22 The heterogeneity
variance t2 was measured. I2 was used to express het-
erogeneity as percentage. A Q value with a significance of
p less than or equal to 0.05 (two-tailed) was considered
significant to reject the null hypothesis. All p-values greater
than 0.05 were evaluated according to the statistical power
of the test. Significant heterogeneity was considered present
when p < 0.05 and I2 > 60%. The impact of each study on
the summary effect was evaluated using the METAN INF
command.
Results
Study Selection and Characteristics
Results of the systematic search and selection of studies
are reported as a PRISMA recommended flow diagram
in Figure 1. The literature search, after removal of duplicates,
identified 1881 articles containing the indicated keywords.
Thirty-eight studies had their full text analyzed for inclu-
sion criteria. As a result of this selection, seven studies were
included in the qualitative synthesis. Four studies examined
changes in adiponectin,23–26 four examined changes in
leptin,25–28 and three evaluated at least one other inflam-
matory marker (IL-6, CRP, TNF-a, plasminogen activator
inhibitor-1, or resistin) preintervention and postinter-
vention.24,22,29 One study, however, was excluded from
quantitative analysis because it did not report numerical
data regarding the evaluation of the outcome.29
Characteristics of the included studies are summarized
in Table 1. Duration of intervention, as well as type, fre-
quency, and intensity of exercise differed between studies.
According to the authors of the included studies, all the
observed effects were considered in relationship to the su-
pervised exercise only. In three studies,25,26,29 the authors
specified that all participants were instructed not to change
their regular physical activity habits or diet during the ex-
periment. Only the study by Kim et al.24 did not include such
statement, while in the studies by Fazelifar et al.,23,27 all
participants were actually requested to avoid doing any ex-
ercise other than that required by the study protocol. Kar-
acabey28 mentioned that all the study participants undertook
the same diet program without providing any further details.
Risk of Bias
Owing to the type of intervention, the blinding of par-
ticipants was not feasible, hence, it was not considered
relevant in the assessment of the bias risk. Similarly, a
low rating was attributed to blinding of the outcome as-
sessment because the main outcome was represented by a
numeric value obtained from independent laboratory tests.
The authors had no conflicts of interest to declare in rela-
tionship to their studies. Consequently, selection, attrition,
reporting, and other possible biases were the main indi-
cators of the validity of the included studies. Risk of bias
assessment is reported graphically in Figure 2. The funnel
plots of standard error of SMD against SMD for
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adiponectin and leptin studies were symmetric and did not
suggest publication bias (Supplementary Fig. S1).
Two studies by Fazelifar et al.23,27 raised concerns about
the possibility of additional bias because they had nu-
merous inconsistencies in the reporting and interpreting of
findings, respectively, in the results and discussion sec-
tions. Moreover, it is possible that both concurrent publi-
cations actually reported the split results of the study on the
same sample without proper cross-referencing. For these
reasons those redundant publications were considered at a
high risk of bias. In the study by Monteiro et al.,29 the
sequence generation was not randomized, hence, we
identified it as having a high risk of selection bias. More-
over, that study failed to report numerical data regarding
the levels of inflammatory cytokines, which is a reason we
considered it at high risk of reporting bias.
Meta-Analysis
Both adiponectin and leptin concentrations showed sig-
nificant differences in pooled effect estimates in favor of
the intervention group. In particular, leptin concentration
(Fig. 3) significantly decreased (SMD -1.13 [95%CI: -1.89
to -0.37], comparison: 0.004; heterogeneity w2 = 19.9,
p = 0.001, I2= 79.9%, t2= 0.601), while adiponectin levels
(Fig. 4) increased with respect to the control group (SMD
0.69 [95%CI: 0.02–1.35], comparison: 0.04; heterogeneity
w2= 15.56, p = 0.004, I2= 74.3%, t2= 0.427).
Other inflammatory markers evaluated in at least two
studies included IL-6, CRP, and TNF-a (Fig. 5). Pooled
data indicated that there was a significant reduction in IL-6
concentration (SMD -0.84 [95%CI: -1.45 to -0.23], com-
parison: 0.007; heterogeneity w2= 1.01, p= 0.315, I2= 0.9%,
t2= 0.002) and a trend in favor of CRP reduction in the
Figure 1. Preferred reporting items for systematic reviews and meta-analyses flow diagram of the study selection process. BMI, body
mass index.
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intervention group. Two studies comparing TNF-a levels
reported discordant results.
TheMETANINF command was used to assess the impact
of each study on the pooled effect on leptin and adipo-
nectin outcome in our meta-analysis. For data regarding
leptin, removing one study at a time did not alter the results,
indicating a minor effect of individual studies on the pooled
estimation and result consistency. Regarding adiponectin, a
nonsignificant increase in favor of the intervention group
emerged after separately deleting the studies by Kim et al.24
and Racil et al.25 (Fig. 6 and Table 2).
Discussion
This study analyzed the effects of exercise on plasma
concentration of inflammatory markers in children with
obesity. Our findings show that the intervention consisting
in physical exercise, without concomitant dietary modifi-
cation or other lifestyle changes, results in an increase in
adiponectin and a decrease in leptin and IL-6 plasma lev-
els. Such changes correspond to a reduction of systemic
inflammation associated with obesity.
To the best of our knowledge, there exist two meta-
analyses, conducted by Garcı´a-Hermoso et al.,30,31 thatT
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Figure 2. Risk of bias identified in the studies included in the
meta-analysis. Low risk of bias is indicated by ‘‘+’’, high risk of
bias ‘‘-’’, unclear risk of bias ‘‘?’’.
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tested a hypothesis similar to ours; their authors concluded
that, in adolescents who had overweight or obesity, exercise
increased adiponectin but did not influence significantly
leptin or CRP levels. Two striking differences, however,
between our meta-analysis and the previously published
analyses are evident. First, we applied a more stringent
assessment of the quality and risk of bias of included trials.
Importantly, it allowed us to identify publications by authors
that presumably focused on quantity rather than quality of
their articles, as two studies were contemporarily published
by the same authors, separately reporting the effects of in-
tervention on leptin and adiponectin levels in the same study
Figure 3. Change in leptin concentration. Squares and the horizontal lines represent the measures of effect, that is, SMD, and associated
confidence intervals for each of the studies and the diamond indicates the summary measure. SMD, standardized mean difference.
Figure 4. Change in adiponectin concentration. Squares and the horizontal lines represent the measures of effect, that is, SMD, and
associated confidence intervals for each of the studies and the diamond indicates the summary measure.
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group.23,27 Segmented publications, indeed, pose a risk to the
strength of future recommendations based on meta-analyses.
Second, the analyses by Garcı´a-Hermoso et al. included both
children with overweight and children with obesity. There
are significant differences between these two groups in cir-
culating levels of adipokines and inflammatory markers in
relationship to BMI, suggesting that these biomarkers may
change from lean to overweight and from overweight to
obesity.32 Hence, from a biochemical perspective, these
two groups can present different profiles of adipokines
and metabolic activity. Such a lack of homogeneity in terms
of participants can make it difficult to provide a meaningful
Figure 5. Change in IL-6, CRP, and TNF concentration. Squares and the horizontal lines represent the measures of effect, that is, SMD,
and associated confidence intervals for each of the studies and the diamond indicates the summary measure.
Figure 6. Influence analysis for adiponectin and leptin.
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summary of the intervention outcome. For this reason, we
decided to include only studies that recruited children
with a BMI greater than the 95th percentile for age and
sex, hence with obesity, according to the World Health
Organization definition.
When the characteristics of the included studies are taken
into consideration, several other differences, apart from
baseline BMI, may have influenced the outcome: prepuberty
or postpuberty age, sex, and type and duration of exercise.
Indeed, substantial heterogeneity was detected for the esti-
mated effects of exercise on adiponectin and leptin levels in
our meta-analysis. Other studies offer possible clues that
indicate some correlation between adipokine levels in
plasma and both sex and type of exercise.
In terms of sex, studies suggest that females with obesity
show higher plasma leptin compared with males.6 Serum
leptin concentrations have been reported to be higher in
women than man,33 and this difference develops with the
onset of puberty, possibly accounting for changes in body
composition.34 Interestingly, apart from the already dis-
cussed functions of leptin, it also appears to play a role
in pubertal development, as suggested by the observations
that obesity during childhood may lead to early signs of
puberty in girls and pubertal delay in boys.35 Even though
a direct relationship between plasma leptin levels and skel-
etal muscle metabolism has not been demonstrated, leptin
receptors have been identified in the skeletal muscle.36 It has
been also found that adiponectin levels in prepubertal boys
are higher than postpuberty,37 while in prepubertal children
with obesity, the levels of adiponectin are lower than in those
with normal weight.38
Incidentally, one study included in our meta-analysis re-
cruited only girls,24 other studies recruited only boys,23,24,27,28
others still included children of both sexes and the results
were pooled.26,29 Of note, all the included studies involved
adolescents, that is, children between the age of puberty
and legal maturity. Further studies are required to elucidate
whether the gender and age-related differences in lep-
tin and adiponectin levels might determine differences
in skeletal muscle and adipose tissue responses to exer-
cise or influence the risk profile for hypertension and
other cardiovascular morbidities associated with obesity
in men and women.
Regarding duration of exercise, the available studies
reported disparate findings on the responses of adiponectin
and leptin to short- and long-term exercise in sedentary and
trained subjects (reviewed by Bouassida et al.).39 In addi-
tion, the type of activity (aerobic, resistance, or concurrent
exercise) can greatly determine the effects of the exercise
on body mass and composition. While aerobic exercise is
considered optimal for reducing body fat, resistance ex-
ercise leads to an increase in lean body mass.40 Arguably,
both these body composition modifications can prevent
chronic diseases related to obesity. Interestingly, data from
a recent clinical trial comparing aerobic, resistance, and
mixed training effects on health suggested that aerobic
training alone was the most efficient mode of exercise for
improving metabolic syndrome.41 Among the studies in-
cluded in our meta-analysis, five included aerobic24–26,28,29
and four included concurrent, aerobic and resistance ex-
ercise groups.23,25,27,29 Two studies directly compared
aerobic and concurrent exercise,25,29 reporting similar de-
creases in body fat in both training groups with respect to
the controls. Only concurrent training induced a significant
increase in lean body mass; in the same group, a signifi-
cantly greater decrease in the plasma leptin/adiponectin
ratio was evident.25 At this point, the available data are
insufficient to draw conclusions regarding the adipokine
response to different modes of exercise.
With regard to IL-6, adipocytes and stromal vascular cells
in the adipose tissue (including pericytes, supra-adventitial
adipose stromal cells, and endothelial cells)42 are capable
of synthesis and secretion of this cytokine.43 Remarkably,
IL-6 is released from skeletal muscle, but not from the
subcutaneous adipose tissue, during exercise in relation-
ship to exercise intensity.44 When these data are taken into
consideration, the findings of the studies of interventions
consisting in physical exercise, with a modification of body
mass and composition, can be difficult to interpret. Even
if available data regarding IL-6 level in children with
obesity and the consequences of exercise intervention on
this inflammatory marker are unclear, data pooled from the
Table 2. Impact of Each Study
on the Pooled Estimate
Study omitted Estimate
CI
low
CI
high
Pooled
estimate
Leptin
Fazelifar et al.27 -1.12 -2.07 -0.16 Significant
Karacabey28 -1.13 -2.15 -0.11 Significant
Racil et al.25 (A) -0.87 -1.64 -0.1 Significant
Racil et al.25 (C) -1.02 -2.0 -0.03 Significant
Vasconcellos
et al.26
-1.48 -1.97 -1.0 Significant
Combined -1.13 -1.89 -0.37 Significant
Adiponectin
Fazelifar et al.23 0.89 0.22 1.56 Significant
Vasconcellos
et al.26
0.82 0.68 1.57 Significant
Kim et al.24 0.73 -0.11 1.56 Not significant
Racil et al.25 (A) 0.44 -0.16 1.05 Not significant
Racil et al.25 (C) 0.55 -0.29 1.38 Not significant
Combined 0.69 0.02 1.35 Significant
The study of Racil et al.25 included groups with two different exercise
protocols: A, aerobic exercise; C, concomitant aerobic plus resistance
exercise.
CI, confidence interval.
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studies included in the present meta-analysis indicated that
there was a significant reduction in IL-6 concentration
following exercise in children with obesity.
In children, achieving compliance with recommenda-
tions can be difficult (indeed, many participants dropped
out of clinical trials included in our meta-analysis). How-
ever, this group should be targeted in programs aimed at
cardiovascular disease prevention, because of the known
association between obesity in childhood and adulthood.1
Dieting alone often fails to achieve long-term benefits in
individuals with obesity45; the possible reason being that
weight loss leads to a reduction in leptin levels, leading in
turn to an increase in hunger.46 The role of physical ac-
tivity and exercise in health and disease extends well beyond
the effects on body weight. Indeed, both weight management
and increased physical activity are currently recommended
for cardiovascular disease prevention.47 If adipose tissue is
regarded as an endocrine organ responding to changes in the
metabolic status, then the systemic regulation of its activity
and modification of the target organ response, rather than
mere reduction in the amount of body fat, should allow for
reduction in obesity-related inflammation for chronic disease
prevention. In light of discussed data, physical exercise
emerges as an optimal measure for achieving this goal.
At present, the evaluation of interventions aimed at
eliminating obesity for cardiovascular and metabolic
disease prevention is commonly based on changes in
anthropometric parameters, body composition, or lipid
and glucose levels. These outcome measures may be
insufficient. As a matter of fact, insulin sensitivity, lipid,
inflammation, and the hormonal profile can present
normal cardioprotective traits in as much as 30% of in-
dividuals with obesity. Interestingly, individuals with
such a metabolically healthy obese phenotype have
higher physical activity and fitness levels when com-
pared with individuals with obesity who present with the
metabolic syndrome.48 Two recent systematic reviews
and meta-analyses indicated an increased risk of cardio-
vascular disease and death in patients with obesity even in
the absence of metabolic abnormalities.49,50 However, when
data were adjusted to account for physical level, individuals
with obesity who were fit did not have an increased risk of
mortality compared with the normal weight fit group.51
Importantly, the increase in circulating leptin observed in
obesity is associated with leptin resistance developing at
both central nervous system and adipose tissue level.
However, in the light of the recent conclusion that direct
activation of adipocyte leptin receptors has little effect on
cell metabolism in vivo,52 the indirect influence of leptin on
adipocytes can play a greater role in adipocyte activity
control. Indeed, there is evidence for leptin inhibiting
insulin secretion and impairing adipocyte insulin re-
sponsiveness in vitro.53 This influence was corroborated
by the results of the clinical study, in which reduced leptin
plasma levels following moderate weight loss in obese
adults correlated with significant improvement of insulin
resistance.54 Taken together, these observations again un-
derscore the role of physical activity for the prevention of
chronic metabolic and cardiovascular disease.
If individuals with obesity can be metabolically healthy,
then individuals with normal weight can have metabolic
obesity. Despite their normal weight, patients with an ac-
cumulation of visceral fat are at increased risk for type 2
diabetes.55 In light of these findings, several markers, such
as waist circumference or visceral adiposity index, emerged
as potentially useful tools for classifying and stratify-
ing cardiovascular risk based on body composition rather
than body mass.56 In adolescents, the levels of adiponectin
and other inflammatory markers correlated with adiposity
evaluated by waist circumference and subscapular and tri-
ceps skinfold measurements.57 Regarding this connection, it
would be important for the future studies to use parameters
describing adiposity rather than weight status for patient
inclusion and randomization when evaluating the effects of
interventions on levels of adipokines in plasma.
Limitations of the Study
The results of the present meta-analysis should be con-
sidered with caution, as several limitations can be identified.
First and foremost, the character of intervention, consisting
in supervised physical exercise, does not allow for blinding
of participants and personnel. However, even if it was not
explicitly specified in the included studies, we assumed that
the laboratory personnel involved in the outcome assess-
ment, that is, blood sample analysis, was blinded to patients’
allocation; hence, we identified a low risk of performance
bias. Second, all the included studies had a small sam-
ple size (less than 100 participants). As discussed above, a
high level of heterogeneity, regarding sex, type, intensity,
and duration of exercise, does not allow for generalization,
and the small numbers of studies and participants make the
adjustment of data infeasible. Third, while STATA soft-
ware allows to test for publication bias, the widely accepted
funnel plot method has several limitations, as true hetero-
geneity, poor methodological design or chance can account
for visual funnel plot asymmetry. According to Higgins
et al.,20 the tests for funnel plot asymmetry should be used
only when there are at least 10 studies included in the meta-
analysis, otherwise the power of the tests is too low to dis-
tinguish chance from real asymmetry.
Another major hurdle in the study of adipokines in
childhood obesity and analysis of the response to exercise
is that leptin and adiponectin expression differs in rela-
tionship to sex and age; in particular, hormonal differences
between boys and girls and between prepubertal and
postpubertal age in both sexes are major determinants of
plasma adipokines. None of the studies included in the
present meta-analysis specifically aimed to address these
issues while investigating or interpreting the effects of
physical exercise on adiponectin and leptin levels. Finally,
even though exercise positively influenced the levels of
adiponectin and leptin in plasma, the significance of the
adipokine level modification as the outcome measure of
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the interventions aimed at weight and cardiovascular risk
reduction remains unknown.
Conclusion
Physical exercise, without concomitant dietary modifi-
cation or other lifestyle changes, is associated with an in-
crease in adiponectin and a decrease in leptin and IL-6
plasma levels in children with obesity, thus reducing the
obesity-associated systemic inflammation. Considering the
role that adipose tissue-derived cytokines play in meta-
bolic homeostasis, it is tempting to suggest that these
and possibly other inflammatory factors may be related
to metabolic syndrome and cardiovascular disease. Hence,
the usefulness of evaluating adipokines in plasma should
continue to be explored in clinical studies both in children
and adults. Studies with a uniform intervention proto-
col and outcome measurements are required to put our
new knowledge on adipose tissue biology into a clinical
perspective.
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